Sorry. ENGLISH page is under construction

The Japanese page is also available (here).

Our team

STAFFs

h_shimizu.dsc@tmd.ac.jp

If you are contacting me for  potential open positions, please attach your CV and clarify your Japanese language proficiency. 
Hideyuki SHIMIZU, MD (Tohoku Univ. JAPAN), PhD (Kyushu Univ. JAPAN)
Professor

Brief sketch:
2022-Current: Dept. AI Systems Medicine, M&D Data Science Center, Tokyo Medical and Dental University
2021-2022: Harvard Medical School, Department of Systems Biology (Prof. Pamela Silver)
2020-2021: Research Associate, Institute of Bioregulation, Kyushu University
2018-2020: Postdoctoral Fellow, Institute of Bioregulation, Kyushu University (Prof. Keiichi Nakayama)
2015-2018: JSPS Research Fellowship for Young Scientists
2012-2014: Resident doctor, Iwate Chubu Hospital

As a physician-scientist, Hideyuki is eager to revolutionize biomedical healthcare by interdisciplinary approaches.

Students

Publications and Talks

【Original Articles】

【Invited Talks (English talk only)】

【Original Articles】

【Talks】

  • Way J, Dobbertin T, Heid D, Chan KR, Vernet A, Sanchez-Ventura M, Graveline A, Burrill D, Lee J, Shimizu H, Niopek D, Silver P. Harnessing the natural trypsin antagonist SPINK-1 for targeted treatment of acute pancreatitis. 52nd Annual Meeting of the American Pancreatic Association. 2021

【Original Articles】

【Review】

【Original Article】

【Invited talks (English only)】

  • Shimizu H, Nakayama KI. Machine learning uncovers novel aspects in healthcare and life science, 第42回日本分子生物学会シンポジウム, 2019
  • Shimizu H, An AI-based Scoring System Precisely Predicts Overall Survival of Breast Cancer Patients. 第14回研究所ネットワーク国際シンポジウム, 2019

【Original Articles】

【Talks】

  • Shimizu H, Matsumoto M, Nakayama KI. Artificial Intelligence Precisely Predicts Overall Survival of Cancer Patients. 第21回九州大学生体防御医学研究所リトリート, 2018
  • Fukushige S, Shimizu H, Sato Y, Horii A. Identification of novel targets for aberrant methylation in pancreatic cancer by a newly developed method “methyl-CpG targeted transcriptional activation (MeTA)”. AACR 101st Annual Meeting 2010
  • Shimizu H, Fukushige S, Horii A. Identification of epigenetically silenced genes by the novel “methyl-CpG targeted transcriptional activation” method in human pancreatic cancer. AACR-JCA 8th Joint Conference, 2010

Contact

Any contacts should be directed to Prof.  Hideyuki SHIMIZU.

  • h_shimizu.dsc@tmd.ac.jp
  • Department of  AI Systems Medicine, M&D Data Science Center, Tokyo Medical and Dental University 
  • 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8510, JAPAN